Source:Economic Times - In a chat with ET Now, Bhavin Shah, CEO, Equirus Securities, shares his views on the Infosys Q4 numbers. Excerpts: ET Now: Your first reading of Infy`s numbers? Bhavin Shah: We have been telling investors to expect Infosys to beat margin expectations in general because
4.24 PM Apr 15th
Source:Economic Times - In a chat with ET Now, Bhavin Shah, CEO, Equirus Securities, shares his view on the Infosys numbers. Excerpts: ET Now: Would you be a buyer in Infosys if the stock cracks today? Bhavin Shah: Yes, we will be a buyer. The margins are below expectations. There is that one time
2.27 PM Oct 12th 2013
a generic version of Nuedexta starting July 30, 2026, or earlier under certain circumstances. On Wednesday, the stock rose 9.3% over the previous close. Bhavin Shah, pharma analyst, Dolat Capital, said the Wockhardt management is doing everything possible to instill confidence among investors. Bhavika
12.46 PM Sep 12th 2013
The market already had expectations of such move, so Narayana Murthy`s return to Infosys may spark some positive reaction by the D-Street on Monday, but a lot of work needs to be done to turnaround the company, says Bhavin Shah, MD at Equirus Securities.
9.23 PM Jun 2nd 2013
of Directors has decided to go ahead with the delisting of the Company from the Ahmedabad Stock Exchange. And for the same, the Board has authorised Mr. Bhavin Shah to carry on the necessary formalities. The listing and trading of equity shares of the Company shall continue on the Bombay Stock Exchange, Mumbai.
5.18 PM May 22nd 2013